Verve pauses base editing trial, shifts strategy after treatment side effect | BioPharma Dive

Retrieved on: 2024-04-02 17:07:22

Tags for this article:

Click the tags to see associated articles and topics

Verve pauses base editing trial, shifts strategy after treatment side effect | BioPharma Dive. View article details on hiswai:

Excerpt

Verve Therapeutics is pausing enrollment into a pioneering study of a gene editing treatment for heart disease, after a participant developed ...

Article found on: www.biopharmadive.com